Cronos (CRON) Income from Continuing Operations (2018 - 2026)
Cronos' (CRON) quarterly Income from Continuing Operations came in at 15711000.0 in Q1 2026, up 103.43% year-on-year from 7723000.0 in Q1 2025, and up 3299.8% quarter-over-quarter from 491000.0 in Q4 2025.
Cronos (CRON) Income from Continuing Operations (2018 - 2026) Analysis & Trends
Cronos' Income from Continuing Operations history runs 9 years deep, the most recent figure standing at 15711000.0 for Q1 2026.
- On a quarterly basis, Income from Continuing Operations rose 103.43% year-over-year to 15711000.0 in Q1 2026; TTM through Mar 2026 was 5059000.0, a 89.93% decrease from a year earlier, with the FY2025 full-year figure at 2929000.0, down 107.32% from the prior year.
- Income from Continuing Operations improved to 15711000.0 in Q1 2026 per CRON's latest filing, from 491000.0 in the prior quarter.
- Across five years, Income from Continuing Operations topped out at 43941000.0 in Q4 2024 and bottomed at 76181000.0 in Q4 2022.
- The 5-year median for Income from Continuing Operations is 5663000.0 (2023), against an average of 10417705.88.
- Across the five-year window, Income from Continuing Operations soared 560.63% in 2024 and sank 339.34% in 2025, its largest moves.
- Year by year, Income from Continuing Operations stood at 76181000.0 in 2022, then soared by 40.73% to 45151000.0 in 2023, then jumped by 197.32% to 43941000.0 in 2024, then plunged by 101.12% to 491000.0 in 2025, then surged by 3299.8% to 15711000.0 in 2026.
- Per Business Quant, the three latest CRON Income from Continuing Operations figures stand at 15711000.0 (Q1 2026), 491000.0 (Q4 2025), and 28321000.0 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 370.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 601.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -3.58 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 274.90 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 176.40 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 197.90 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 57.00 Mn |
| 10 | Cronos | 1.04 Bn | 267.78 Mn | 19.15 Mn | 15.71 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 15.71 Mn |
| Dec 31, 2025 | -491,000.00 |
| Sep 30, 2025 | 28.32 Mn |
| Jun 30, 2025 | -38.48 Mn |
| Mar 31, 2025 | 7.72 Mn |
| Dec 31, 2024 | 43.94 Mn |
| Sep 30, 2024 | 7.32 Mn |
| Jun 30, 2024 | -8.76 Mn |
| Mar 31, 2024 | -2.48 Mn |
| Dec 31, 2023 | -45.15 Mn |
| Sep 30, 2023 | -1.59 Mn |
| Jun 30, 2023 | -5.66 Mn |
| Mar 31, 2023 | -18.04 Mn |
| Dec 31, 2022 | -76.18 Mn |
| Sep 30, 2022 | -33.11 Mn |
| Jun 30, 2022 | -17.53 Mn |
| Mar 31, 2022 | -32.65 Mn |
| Dec 31, 2021 | 134.73 Mn |
| Sep 30, 2021 | 77.58 Mn |
| Jun 30, 2021 | -178.79 Mn |